Friday, July 10, 2026

pharma · Steroid refractory Acute Graft versus host Disease · moderate to severe atopic dermatitis

Medac Gesellschaft fuer

Medac Gesellschaft fuer trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
3
Drugs
14
Patents
0
Intelligence · Clinical Trials

Medac Gesellschaft fuer clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Medac Gesellschaft fuer programs — each row shows trial ID, program name, phase, status, and indication.

Medac Gesellschaft fuer trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Medac Gesellschaft fuer.

  1. MC-FludT.18/QT — Phase 1

    Clinical update
  2. MC-MTX.18/AD — Phase 3

    Clinical update
  3. MC-MSC.1/aGvHD — Phase 3

    Clinical update

Trial registry

3 studies